Contact us

Acacia acquires Biotech Stakes: an insight into the companies and patents behind the deal

Share this page:

On 5th June, a portfolio of shares in 19 life science companies was agreed to be sold by Neil Woodford’s LF Equity Income Fund to Acacia Research for up to £224 million. To date, nine assets have been transferred to Acacia Research, many of these have already been sold on.

Find out in our latest article which companies and patents are involved in this deal as well as what this says about Acacia’s strategy.

‘Acacia acquires Biotech Stakes’ PDF Download



Gain an insight into the companies and patents behind the deal

  • Which companies are involved in this transaction?
  • What can this tell us about Acacia Research’s overall strategy?
  • What information has been kept in the dark?

Acacia acquires Biotech Stakes report

Insights & Events

Beyond portfolio optimisation – calculating the value of rightsizing

View our webinar discussing results of the Cipher Report on Portfolio Optimisation and the optimisation model that can help you balance your portfolio.
Read more

Look before you leap: is litigation the best strategy for Sonos?

The Sonos-Google litigation dispute – where do we go from here?
Read more

With Cipher you can…

Optimise your portfolio

Ensure you have the right portfolio to meet your strategic patenting objectives.

Read more

Gather competitor intelligence

Understand who’s doing what by automating patent to technology mapping.

Read more

Model cross licensing

Combine patent and revenue data to determine rational licensing outcomes.

Read more

Manage your budget

Justify patent budgets to CFOs and others to communicate the impact of your investment.

Read more

Conduct due diligence

Automate manual reviews for efficient execution of M&A and licensing transactions.

Read more

Tackle inbound patent assertion

Be prepared with evidence to create a fast and effective threat assessment.

Read more

Benchmark your portfolio

Assess your portfolio in comparison to other owners through your technology lens.

Read more

Monetise your portfolio

Identify opportunities to create value through licensing or sale of patent assets.

Read more

Improve your patent strategy now

Speak to one of our Cipher team today.